PANews reported on February 5th that, according to CoinDesk, cryptocurrency exchange Bullish released its Q4 2025 financial results, reporting a net loss of $563PANews reported on February 5th that, according to CoinDesk, cryptocurrency exchange Bullish released its Q4 2025 financial results, reporting a net loss of $563

Bullish reported a fourth-quarter loss of $563.6 million, and its stock price fell 5%.

2026/02/05 20:50
1 min read

PANews reported on February 5th that, according to CoinDesk, cryptocurrency exchange Bullish released its Q4 2025 financial results, reporting a net loss of $563.6 million, compared to a net profit of $158.5 million in the same period last year. The company reported a loss of $3.73 per share, primarily attributed to losses from the remeasurement of non-cash digital assets. Following the release of the financial report, its stock price fell 5% in pre-market trading.

The report shows that the platform's spot trading volume reached $64.3 billion in the quarter. The company launched its spot trading business in the US last September, simultaneously introducing options trading, with options trading volume reaching $9 billion in the same quarter. Bullish plans to list on the New York Stock Exchange via direct listing in August 2025; previously, it was a privately held exchange focused on institutional clients.

Market Opportunity
Bullish Degen Logo
Bullish Degen Price(BULLISH)
$0.006223
$0.006223$0.006223
+12.59%
USD
Bullish Degen (BULLISH) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.